Tamoxifen: Will Less Equal More in Women with Precancerous Breast Disease?
被引:0
|
作者:
Fabian, Carol J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Kansas, Div Clin Oncol, Dept Internal Med, Med Ctr, Kansas City, KS USAUniv Kansas, Div Clin Oncol, Dept Internal Med, Med Ctr, Kansas City, KS USA
Fabian, Carol J.
[1
]
机构:
[1] Univ Kansas, Div Clin Oncol, Dept Internal Med, Med Ctr, Kansas City, KS USA
Similar risk reduction but fewer side effects would predict more uptake and compliance with low (5 mg) versus full (20 mg) dose tamoxifen. Benefit with low dose is demonstrated for perimenopausal/postmenopausal women with intraepithelial neoplasia and high lesion Ki-67. Longer follow-up needed to determine benefit with low lesion Ki-67.